封面
市场调查报告书
商品编码
1628788

北美泡壳包装:市场占有率分析、产业趋势、成长预测(2025-2030)

North America Blister Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

北美泡壳包装市场预计在预测期内复合年增长率为 7.5%

北美吸塑包装-市场-IMG1

主要亮点

  • 泡壳包装在北美地区正在温和成长。泡壳包装解决方案提供的高安全性正在推动需求。严格的法规以及製造商和消费者的需求导致泡壳包装的使用增加。非处方药的成长也重振了市场。
  • 不断上升的发病率和政府对假药的严格监管迫使製药公司生产包装不同的药品,这些药品比继续为患者提供符合其生产目的的药品的基本需求更难模仿,压力越来越大。推动市场的一个主要因素。泡壳包装描述了防伪系统(例如钞票认证系统)的一种有效方法。
  • RFID(无线射频识别标籤)等创新技术部署在泡壳中并在包装外部贴上贴纸,有可能在整个供应链中提供个人安全,其使用量正在增加。只有当保护屏障被破坏并且分配和施用单一胶囊或锭剂时,才会发生泡壳内样品的污染。
  • 供应商也专注于环保泡壳包装解决方案并推出纸质泡壳包装。例如,2021 年 7 月,Hutamaki Oyj 推出了 Push Tab,这是医疗产业的纸本泡壳包装解决方案。该产品经过 FSC 认证,旨在满足受监管药品包装的严格安全要求。

北美泡壳包装市场趋势

药品预计将显着成长

  • 製药领域对泡壳包装解决方案有不同的要求,例如与外部环境隔离、成本效益、高级保护、易于处理以及保存药效等。这些包装特别适合满足严格的法规,并因其保护性能、成本效益、适应性和药品包装行业的需求而受到重视。
  • 当药物包装在泡壳包装中时,消费者知道他们的药物和剂量,从而提高用药依从性。泡壳的单位剂量特征降低了错误剂量的风险。
  • 零售层面的处方药製备对于製药技术人员和药剂师来说是一个挑战。在超级市场和药局的开放环境中给药可能会对敏感药物在容器之间转移时产生不利影响。泡壳包装可以确保直接配送给客户的过程。
  • 虽然保护产品完整性仍然是药品包装的首要目标,但包装产业的所有领域都在继续努力降低包装过程中的成本。
  • 例如,Amcor 的 Polybar 阻隔薄膜系列涵盖广泛的防潮阻隔性,具有出色的抗压性能,可确保为锭剂和胶囊等製药应用提供最佳保护。我们使用 Aclar、COC、PE、PVC、PVdc 等材料。
  • 此外,服务于固态製剂领域的製药公司正在投资扩大北美的生产设施。例如,2020 年 9 月,Aphena Pharma Solutions 宣布扩建其位于田纳西州库克维尔的固态製剂部门。该公司的目标是为该工厂配备 24 条高速装瓶线和 8 条热成型泡壳包装线。由此可见该地区对泡壳包装的需求。
  • 此外,根据欧洲製药工业和协会联合会的数据,2020 年北美占药品销售额的 49%。这导致该地区对各种泡壳包装的需求增加。

美国占最大市场占有率

  • 严格的法规以及製造商和消费者的要求导緻美国泡壳包装的使用增加。製造商寻求透过根据这些监管标准製造产品来获得税收优惠。非处方药的加速成长也刺激了市场。
  • 多种慢性病正在推动美国对药品的需求。药品製造商推出并发明了具有先进功效的有效药物。 FDA新药认证数量也显着增加。
  • 在泡壳包装过程中,单一锭剂或胶囊被密封在通常由热成型塑胶或冷成型铝製成的空腔内,铝箔、薄膜或纸板等屏障可以保护药物免受水分和氧气等污染物的影响。此外,根据美国人口普查局的数据,到 2024年终,药品製造业可能会达到 365,000 家。这进一步推动了该国的市场研究。
  • 此外,这场大流行促使世界各地研究开发新冠肺炎 (COVID-19) 疫苗。例如,医疗保健巨头强生公司于 2020 年 9 月启动了临床测试,并透过美国卫生与公众服务部获得了约 5 亿美元的合作关係。

北美泡壳包装产业概况

北美泡壳包装市场适度细分。伙伴关係、併购和收购已成为市场上供应商生产最终用户行业可接受的产品的重要策略,其中包装材料经过严格的品质检查,以确保它们不会污染内容物并影响健康。维持原料的持续流动仍是促进伙伴关係的挑战。该市场的主要参与企业包括 Amcor Ltd、Westrock Company、Sonoco Products Company、Constantia Flexibles GmbH 和 Honeywell International Inc.。

  • 2021 年 4 月 - Amcor 宣布对可回收聚乙烯基热成型泡壳包装进行客户测试。这种新包装旨在满足高度专业化和监管的药品包装的严格要求,为最受欢迎的医疗包装类型创造更永续的选择。与市售包装替代品相比,这项创新可减少高达 70% 的碳足迹。
  • 2021 年 7 月 - Huthamaki 推出适用于医疗产业的纸质泡壳包装「Pushtab」。该公司使用的纸张经过 FSC 认证,可取代由热成型 PVC 或铝製成的传统推入式包装,从而减少整个价值链对环境的影响。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 市场驱动因素
    • 老年人口增加与疾病传播
    • 产品创新,例如相对便宜的小型化
  • 市场问题
    • 法规的动态性和缺乏处理重负载的能力
  • 产业吸引力-波特五力分析
    • 供应商的议价能力
    • 消费者议价能力
    • 新进入者的威胁
    • 竞争公司之间的敌对关係
    • 替代品的威胁
  • 评估 COVID-19 对泡壳包装市场的影响

第五章市场区隔

  • 按流程
    • 热成型
    • 冷成型
  • 按材质
    • 塑胶薄膜
    • 纸/纸板
    • 其他的
  • 按最终用户产业
    • 消费品
    • 药品
    • 工业的
    • 其他的
  • 按国家/地区
    • 美国
    • 加拿大

第六章 竞争状况

  • 公司简介
    • Amcor PLC
    • Westrock Company
    • Constantia Flexibles GmbH
    • Sonoco Products Company
    • Klockner Pentaplast Group
    • EI Du Pont De Nemours and Company
    • Honeywell International Inc.
    • The Dow Chemical Company
    • Tekni-Plex Inc.

第七章 投资分析

第八章市场的未来

简介目录
Product Code: 54335

The North America Blister Packaging Market is expected to register a CAGR of 7.5% during the forecast period.

North America Blister Packaging - Market - IMG1

Key Highlights

  • Blister packaging is witnessing moderate growth in the North American region. The high safety offered by blister packaging solutions is augmenting the demand for these solutions. The strict regulations and demand from manufacturers and consumers alike have led to growth in the usage of blister packages. Growth in over-the-counter drugs has also provided an impetus to the market.
  • Growing pressure on pharmaceutical companies to manufacture medicines that are different in packaging and hard to imitate, surpassing the basic need of keeping it useful for the purpose it was produced, for it to be made available for patients, due to growth in diseases and stringent government regulations against counterfeit drugs, are among the significant factors propelling the market. Blister packaging provides an efficient method of anti-counterfeit systems, like banknote authentication systems and others.
  • The use of innovative technologies in blisters, such as RFID (radio frequency identification tags), deployed with a seal applied outside the packaging, is increasing due to the potential to offer individual security throughout supply chains. Contamination of samples in blisters only occurs when the protective barrier is broken, when a single capsule or tablet is dispensed or administered.
  • Vendors are also focusing on environmentally friendly blister packaging solutions and are introducing paper-based blister packaging. For instance, in July 2021, Hutamaki Oyj launched Push Tab, a paper-based blister solution for the healthcare industry. The product is certified by FSC and is designed to meet stringent safety requirements of regulated pharmaceutical packaging.

North America Blister Packaging Market Trends

Pharmaceutical is Expected to Witness a Significant Growth

  • The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine. These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
  • When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
  • The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
  • Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry.
  • For instance, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
  • Further, the pharmaceutical companies catering to solid dose division are investing in the expansion of manufacturing facilities in North America. For instance, in September 2020, Aphena Pharma Solutions announced the expansion of the solid dose division in Cookeville, Tennessee. The comany has aimed to equip the facility with 24 high-speed bottling lines and eight thermoform blister packaging lines. This indicates the demand for blister packaging in the region.
  • Moreover, according to The European Federation of Pharmaceutical Industries and Associations, North America accounted for 49% of the pharmaceutical revenue in 2020 compared to other regions across the globe. This increases demand for various blister packaging in the region.

United States to Hold the Largest Market Share

  • Strict regulations, demands from manufacturers and consumers alike have led to growth in the usage of blister packages in the United States. The manufacturers are looking to earn tax incentives by manufacturing products under these regulatory standards. The promotion of Growth in over-the-counter drugs and has also provided an impetus to the market.
  • Various chronic diseases raised the demand for drugs in the United States. Drug manufacturers introduced and invented effective drugs with advanced efficacies. This market also witnessed significant growth in the number of newer drug approvals given by the FDA.
  • Under the blister packaging process, individual tablets or capsules are sealed within their own cavity, usually made of thermo-formed plastic or cold-form aluminum, protecting the drug from contaminants such as moisture and oxygen by a barrier of foil, film, or paperboard. Also, according to US Census Bureau, the manufacturing of pharmaceutical products could reach 365 thousand by the end of 2024. This further drives the market studied in the country.
  • Furthermore, the outbreak has increased the research across the world for developing a vaccine for COVID-19. For instance, the healthcare giant, Johnson & Johnson, started clinical trials in September 2020 and has received a nearly USD 500 million partnership via a US Department of Health and Human Services division.

North America Blister Packaging Industry Overview

The North America Blister Packaging Market is moderately fragmented. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing products that are acceptable in the end-user industry, where packaging materials undergo stringent quality tests not to contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships. Some of the major players in the market are Amcor Ltd, Westrock Company, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International Inc., among others.

  • April 2021 - Amcor announced customer trials for recyclable Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint when compared to packaging alternatives on the market.
  • July 2021 - Huthamaki launched Push Tab paper-based blister solution for the healthcare industry. The paper used by the comany is FSC certified and acts as an alternative to traditional push-through packaging made of thermoformed PVC and aluminum, thus reducing the environmental impact across the value chain.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing geriatric population and prevalence of diseases
    • 4.2.2 Product innovations such as downsizing coupled with relatively low costs
  • 4.3 Market Challenges
    • 4.3.1 Dynamic nature of regulations and inability to support heavy goods
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Intensity of Competitive Rivalry
    • 4.4.5 Threat of Substitutes
  • 4.5 Assessment of the Impact of COVID-19 on Blister Packaging Market

5 MARKET SEGMENTATION

  • 5.1 By Process
    • 5.1.1 Thermoforming
    • 5.1.2 Coldforming
  • 5.2 By Material
    • 5.2.1 Plastic Films
    • 5.2.2 Paper and Paperboard
    • 5.2.3 Aluminum
    • 5.2.4 Other Materials
  • 5.3 By End-User Industry
    • 5.3.1 Consumer Goods
    • 5.3.2 Pharmaceutical
    • 5.3.3 Industrial
    • 5.3.4 Other End-User Industries
  • 5.4 By Country
    • 5.4.1 United Sates
    • 5.4.2 Canada

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amcor PLC
    • 6.1.2 Westrock Company
    • 6.1.3 Constantia Flexibles GmbH
    • 6.1.4 Sonoco Products Company
    • 6.1.5 Klockner Pentaplast Group
    • 6.1.6 E.I. Du Pont De Nemours and Company
    • 6.1.7 Honeywell International Inc.
    • 6.1.8 The Dow Chemical Company
    • 6.1.9 Tekni-Plex Inc.

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET